In summary, our research reveals that TRIB3 promotes the progression of RCC by upregulating the lipid droplet-associated protein PLIN2, as shown in Fig 8D. This TRIB3-PLIN2 axis thus represents a promising new target for efforts to treat RCC. The gene discussed is PLIN2; the disease is renal cell carcinoma.